483 Sinsin Pharmaceutical Mar 2012

483 Sinsin Pharmaceutical Mar 2012

Nicholas Violand FDA$119.00 - Available Now

FDA investigators audited the Sinsin Pharmaceutical - Ansansi Danweon-gu, Korea (the Republic of) facility and issued inspectional observations (via FDA 483) on 02 Mar 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 02 Mar 2012
  • Location: Ansansi Danweon-gu, Korea (the Republic of)
  • FEI: 3002277609
Add To Cart